This webinar is an AAOS member benefit: Members attend for free! 

Description

Diabetic charcopathic arthropathy remains one of the most challenging pathologies facing orthopedic surgeons. The aim of this symposium is to provide insight on various treatment options for this pathology, ranging from early surgical preventive intervention, through treatment of various anatomical regions of the ankle and foot and the role of new treatment modalities such as distraction osteogenesis for infected cases. The symposium aims to provide a refresher for the generalist and to give
them the tools to medically optimize these patients as well as to provide a learning forum for those who actively treat Charcot deformities on a daily basis.

Learning Objectives

• Identifying new algorithms in managing the early charcopathic ankle and foot and potential role for early surgical intervention 
• Managing complex charcopathic deformities of the ankle as well as combined ankle and hindfoot deformities, including the “Triple Attack” theory with an evidenced based approach
• Approaching the midfoot Charcot and discussing the debate between the “Super construct” with a stabilized midfoot versus the “Flipper Foot"

Director

Christopher Gross, MD, FAAOS

Faculty

Amgad Haleem, MD, Veerabhadra Reddy, MD, Daniel Scott, MD, Max Michalski, MD 

The American Academy of Orthopaedic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Access to the recording will be granted for a duration of 2 years.